Inventor
CONVERSO ANTONELLA
US12 patents
⚠️ This page may combine multiple inventors who share the name “CONVERSO ANTONELLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
6 patentsUS9278960B2Mar 8, 2016
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME4 citations82
US9663506B2May 30, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US9636337B2May 2, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US10376504B2Aug 13, 2019
Substituted quinolinones as PDE9 inhibitors
MERCK SHARP & DOHME2 citations67
US10370336B2Aug 6, 2019
Phenyl-cyanoquinolinone PDE9 inhibitors
MERCK SHARP & DOHME1 citations52
US10370337B2Aug 6, 2019
Oxy-cyanoquinolinone PDE9 inhibitors
MERCK SHARP & DOHME0 citations46
MERCK SHARP & DOHME LLC
4 patentsUS12258329B2Mar 25, 2025
Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells
MERCK SHARP & DOHME LLC0 citations62
US12558357B2Feb 24, 2026
Tetrahydroquinazoline derivatives as selective cytotoxic agents
MERCK SHARP & DOHME LLC0 citations59
US11648250B2May 16, 2023
Tetrahydroquinazoline derivatives as selective cytotoxic agents
MERCK SHARP & DOHME LLC0 citations59
US12492183B2Dec 9, 2025
Tetrahydroquinazoline derivatives as selective cytotoxic agents
MERCK SHARP & DOHME LLC0 citations49